# Cue Biopharma, Inc.: Form 8-K, filed Nov 24, 2025

- Company: [Cue Biopharma, Inc.](/companies/cue.md) (CIK 1645460)
- Form: 8-K
- Filed: 2025-11-24
- Accepted by EDGAR: Nov 24, 2025, 08:08 ET
- Period: 2025-11-24
- Accession: 0001193125-25-292093
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1645460/000119312525292093/cue-20251124.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645460/000119312525292093/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645460/000119312525292093/cue-20251124.htm

Filed Nov 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-292093. Last ingested by Listed: Nov 11, 2026, 02:48 ET. No prices; not investment advice.
